2022-2024
1: D'Amato M, Campagnoli M, Iadarola P, Bignami PM, Fumagalli M, Chiarelli LR, Stelitano G, Meloni F, Linciano P, Collina S, Pietrocola G, Vertui V, Aliberti A, Fossali T, Viglio S. Could the Oxidation of α1-Antitrypsin Prevent the Binding of Human Neutrophil Elastase in COVID-19 Patients? Int J Mol Sci. 2023 Aug 31;24(17):13533. doi: 10.3390/ijms241713533. PMID: 37686340; PMCID: PMC10488172.

2: Caminati A, Meloni F, Fujita M. Editorial: Idiopathic pulmonary fibrosis: epidemiology, prognosis and treatment. Front Med (Lausanne). 2023 Jun
1;10:1195263. doi: 10.3389/fmed.2023.1195263. PMID: 37324135; PMCID: PMC10267469.

3: Urso A, Meloni F, Malatesta M, Latorre R, Damoci C, Crapanzano J, Pandolfi L, Giustra MD, Pearson M, Colombo M, Schilling K, Glabonjat RA, D'Ovidio F. Endotracheal nebulization of gold nanoparticles for noninvasive pulmonary drug delivery. Nanomedicine (Lond). 2023 Feb;18(4):317-330. doi:10.2217/nnm-2022-0179. Epub 2023 May 4. PMID: 37140430.

4: Magouliotis DE, Bos S, Esendagli D, Nardini M, Migliore M, Perch M, Cardillo G, Meloni F, Ricciardi S, Hellemons M. ERS International Congress 2022: highlights from the Thoracic Surgery and Lung Transplantation Assembly. ERJ Open Res. 2023 Apr 17;9(2):00671-2022. doi: 1183/23120541.00671-2022. PMID: 37077552; PMCID: PMC10107066.

5: Matuozzo D, Talouarn E, Marchal A, Zhang P, Manry J, Seeleuthner Y, Zhang Y, Bolze A, Chaldebas M, Milisavljevic B, Gervais A, Bastard P, Asano T, Bizien L, Barzaghi F, Abolhassani H, Abou Tayoun A, Aiuti A, Alavi Darazam I, Allende LM, Alonso-Arias R, Arias AA, Aytekin G, Bergman P, Bondesan S, Bryceson YT, Bustos IG, Cabrera-Marante O, Carcel S, Carrera P, Casari G, Chaïbi K, Colobran R,Condino-Neto A, Covill LE, Delmonte OM, El Zein L, Flores C, Gregersen PK, GutM, Haerynck F, Halwani R, Hancerli S, Hammarström L, Hatipoğlu N, Karbuz A,Keles S, Kyheng C, Leon-Lopez R, Franco JL, Mansouri D, Martinez-Picado J, MetinAkcan O, Migeotte I, Morange PE, Morelle G, Martin-Nalda A, Novelli G, NovelliA, Ozcelik T, Palabiyik F, Pan-Hammarström Q, de Diego RP, Planas-Serra L,Pleguezuelo DE, Prando C, Pujol A, Reyes LF, Rivière JG, Rodriguez-Gallego C,Rojas J, Rovere-Querini P, Schlüter A, Shahrooei M, Sobh A, Soler-Palacin P,Tandjaoui-Lambiotte Y, Tipu I, Tresoldi C, Troya J, van de Beek D, Zatz M,Zawadzki P, Al-Muhsen SZ, Alosaimi MF, Alsohime FM, Baris-Feldman H, Butte MJ,Constantinescu SN, Cooper MA, Dalgard CL, Fellay J, Heath JR, Lau YL, Lifton RP,Maniatis T, Mogensen TH, von Bernuth H, Lermine A, Vidaud M, Boland A, Deleuze JF, Nussbaum R, Kahn-Kirby A, Mentre F, Tubiana S, Gorochov G, Tubach F,Hausfater P; COVID Human Genetic Effort; COVIDeF Study Group; French COVID Cohort Study Group; CoV-Contact Cohort; COVID-STORM Clinicians; COVID Clinicians; Orchestra Working Group; Amsterdam UMC Covid-19 Biobank; NIAID-USUHS COVID Study Group; Meyts I, Zhang SY, Puel A, Notarangelo LD, Boisson-Dupuis S, Su HC, Boisson B, Jouanguy E, Casanova JL, Zhang Q, Abel L, Cobat A. Rare predicted loss-of-function variants of type I IFN immunity genes are associated with life-threatening COVID-19. Genome Med. 2023 Apr 5;15(1):22. doi:10.1186/s13073-023-01173-8. PMID: 37020259; PMCID: PMC10074346.

6: Bozzini S, Della Zoppa M, Bagnera C, Bozza E, Croce S, Valsecchi C, Belliato M, Pandolfi L, Morbini P, Comoli P, Avanzini MA, Meloni F. Lung mesenchymal cells from patients with COVID-19 driven lung fibrosis: Several features with CTD-ILD derived cells but with high